Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alx Oncology Holdings Inc shares valued at $46,404 were purchased by Hemrajani Rekha on Dec 02 ’24. At $1.55 per share, Hemrajani Rekha acquired 30,000 shares. The insider’s holdings grew to 33,000 shares worth approximately $60720.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Pinto Shelly sold 564 shares, netting a total of over 1,455 in proceeds. Following the sale of shares at $2.58 each, the insider now holds 91,549 shares.
Before that, Randolph Sophia had sold 1,365 shares from its account. In a trade valued at $3,522, the CHIEF MEDICAL OFFICER traded Alx Oncology Holdings Inc shares for $2.58 each. Upon closing the transaction, the insider’s holdings decreased to 1,365 shares, worth approximately $0.6 million.
As published in a research note from Stifel on March 08, 2024, Alx Oncology Holdings Inc [ALXO] has been rated down from a Buy to a Hold and the price target has been revised to $14 from $10. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early December. As of December 22, 2021, Jefferies has decreased its “Buy” rating to a “Hold” for ALXO. Earlier on September 30, 2021, Stifel initiated its rating. Their recommendation was “a Buy” for ALXO stock.
Analyzing ALXO Stock Performance
During the last five days, there has been a surge of approximately 21.85%. Over the course of the year, Alx Oncology Holdings Inc shares have dropped approximately -87.64%. Shares of the company reached a 52-week high of $17.8250 on 05/07/24 and a 52-week low of $1.1900 on 11/19/24. A 50-day SMA is recorded $1.4921, while a 200-day SMA reached $6.5392. Nevertheless, trading volume fell to 3.21 million shares from 1.73 million shares the previous day.
Support And Resistance Levels for Alx Oncology Holdings Inc (ALXO)
According to the 24-hour chart, there is a support level at 1.6633, which, if violated, would cause prices to drop to 1.4867. In the upper region, resistance lies at 2.0333. The next price resistance is at 2.2267. RSI (Relative Strength Index) is 61.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1140, which suggests the price will decrease in the coming days. Percent R is at 32.31%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
